How to calculate vascular age with the SCORE project scales: A new method of cardiovascular risk evaluation

European Heart Journal

Volumn 31, Issue 19, 2010, Pages 2351-2358

  Cuende, José I ^a   Cuende, Natividad ^b   Calaveras Lagartos, Javier ^c  

^a Gerencia Regional de Salud de Castilla y León   (Spain)

^b JUNTA DE ANDALUCÍA   (Spain)

^c Primary Health Service   (Spain)

Author keywords

Agreement; SCORE; Vascular age

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULAR BIOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 77957689756     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq205     Document Type: Article

References (19)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press 2008.
2. World Health Organization. www.who.int/healthinfo/global-burden-disease/ DTH6 2004.xls (12 August 2009).
3. Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European Cardiovascular Disease Statistics, 2008 Edition. European Heart Network. www.ehnheart.org/cms/site/showdoc.asp?id=7071 (12 August 2009).
4. De la Peña-Fernandez A, Suarez-Fernandez C, Cuende-Melero I, Munoz-Rodriguez M, Garre-Canovas J, Camafort-Babkowski M, Roca Villanueva B, Alcalá Pedraja J, Grupo estudio CIFARC. Grupo Riesgo Vascular SEMI. Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC Project Med Clin (Barc) 2005;124:44-49.
5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. 2007 ESH-ESC guidelines for the management of arterial hypertension\the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28: 1462-1536.
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-2414.
7. Conroy RM, Pyö rälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24: 987-1003.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-1610.
9. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717-725.
10. Cuende JI, Acebal A, Abad Fernández JL, Alvarez López J, de Miguel Gutiérrez A, Triana Sánchez JM, Durántez Cacharro M, Donis Domeque J, Grupo ERVPA. Risk percentiles: a new adapted method for evaluating vascular risk. ERVPA Study Med Clin (Barc) 2004;123:121-126.
11. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health 1951;41: 279-286.
12. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Fra-mingham Heart Study. Circulation 2008;117:743-753.
13. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. Eur J Cardiovasc Prev Rehabil 2005;12:442-450.
14. Buitrago F, Cañón-Barroso L, D́?az-Herrera N, Cruces-Muro E, Escobar-Fernández M, Serrano-Arias JM. Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment. Rev Esp Cardiol 2007;60: 139-147.
15. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-187.
16. Cuende JI, Acebal A, Carrera-Camarón A, Salado-Cuadrado F, D́?ez-Cordero F, Blanco-Urzáiz I, Redondo-Valdeolmillos M, Garć?a-Vallejo N. Cardiovascular risk percentiles avoid overestimation or underestimation of risk calculated by the SCORE risk function. Rev Esp Salud Publica 2006;80:125-138.
17. Hakes JK, Viscusi WK. Dead reckoning: demographic determinants of the accuracy of mortality risk perceptions. Risk Anal 2004;24:651-664.
18. Reeves MJ, Rafferty AP. Health lifestyle characteristics among adults in the United States, 2000. Arch Intern Med 2005;165:854-857.
19. Misselbrook D, Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract 2000;51:276-279.